Discovery of 2-aminoimidazole and 2-amino imidazolyl-thiazoles as non-xanthine human adenosine A3 receptor antagonists: SAR and molecular modeling studies.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  MedChemComm

• Publication date

  2018-04-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c7md00643hPMID 30108958PMCID PMC6072342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations

  2015cited by this paper
• Advances in Computational Techniques to Study GPCR-Ligand Recognition.

  2015cited by this paper
• Novel thiazole-thiophene conjugates as adenosine receptor antagonists: synthesis, biological evaluation and docking studies.

  2015cited by this paper
• Alternative Quality Assessment Strategy to Compare Performances of GPCR-Ligand Docking Protocols: The Human Adenosine A2A Receptor as a Case Study

  2014cited by this paper
• New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides.

  2013cited by this paper
• Implementing the “Best Template Searching” tool into Adenosiland platform

  2013cited by this paper
• G protein-coupled receptors: computer-aided ligand discovery and computational structural analyses in the 2010s

  2013cited by this paper
• Adenosiland: walking through adenosine receptors landscape.

  2012cited by this paper
• 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.

  2010cited by this paper
• Adenosine receptors and asthma

  2008cited by this paper
• CGH2466, a combined adenosine receptor antagonist, p38 mitogen‐activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti‐inflammatory activities

  2005cited by this paper
• Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.

  2005cited by this paper
• Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma.

  2005cited by this paper
• Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation.

  2004cited by this paper
• New highly potent and selective adenosine A(3) receptor antagonists.

  2004cited by this paper
• Non‐Xanthine Antagonists for the Adenosine A1 Receptor

  2004cited by this paper
• Activation of A3 Adenosine Receptors Attenuates Lung Injury after In Vivo Reperfusion

  2004cited by this paper
• Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma.

  2004cited by this paper
• A glance at adenosine receptors: novel target for antitumor therapy.

  2003cited by this paper
• KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist.

  2002cited by this paper
• Knockout of A3 adenosine receptors reduces mouse intraocular pressure.

  2002cited by this paper
• International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

  2001cited by this paper
• Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor

  2001cited by this paper
• Therapy of bronchial asthma with adenosine receptor agonists or antagonists.

  2001cited by this paper
• New potent and selective human adenosine A(3) receptor antagonists.

  2000cited by this paper
• Structure and function of adenosine receptors and their genes

  2000cited by this paper
• Adenosine A3 receptors: novel ligands and paradoxical effects.

  1998cited by this paper
• Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium.

  1996cited by this paper
• A3-adenosine receptors: design of selective ligands and therapeutic prospects.

  1995cited by this paper
• Adenosine A3 receptor stimulation and cerebral ischemia.

  1994cited by this paper

• Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents

  2022cites this paper
• Metal-free synthesis of Imidazoles and 2-aminoimidazoles

  2022cites this paper
• Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development

  2021cites this paper
• Adenosine receptor antagonists: Recent advances and therapeutic perspective.

  2021cites this paper
• Chemical diversity of zoantharians from the coast of Ecuador in the tropical eastern Pacific

  2019cites this paper